| Year |
Citation |
Score |
| 2020 |
Sheng YH, Leu WJ, Chen CN, Hsu JL, Liu YT, Hsu LC, Hou DR, Guh JH. The (+)-Brevipolide H Displays Anticancer Activity against Human Castration-Resistant Prostate Cancer: The Role of Oxidative Stress and Akt/mTOR/p70S6K-Dependent Pathways in G1 Checkpoint Arrest and Apoptosis. Molecules (Basel, Switzerland). 25. PMID 32630532 DOI: 10.3390/molecules25122929 |
0.347 |
|
| 2020 |
Leu WJ, Wang CT, Hsu JL, Chen IS, Chang HS, Guh JH. Ascleposide, a natural cardenolide, induces anticancer signaling in human castration-resistant prostatic cancer through Na /K -ATPase internalization and tubulin acetylation. The Prostate. PMID 31905252 DOI: 10.1002/pros.23944 |
0.314 |
|
| 2019 |
Li YL, Weng HC, Hsu JL, Lin SW, Guh JH, Hsu LC. The Combination of MK-2206 and WZB117 Exerts a Synergistic Cytotoxic Effect Against Breast Cancer Cells. Frontiers in Pharmacology. 10: 1311. PMID 31780937 DOI: 10.3389/fphar.2019.01311 |
0.341 |
|
| 2017 |
Chan ML, Yu CC, Hsu JL, Leu WJ, Chan SH, Hsu LC, Liu SP, Ivantcova PM, Dogan Ö, Bräse S, Kudryavtsev KV, Guh JH. Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways. Oncotarget. PMID 28586754 DOI: 10.18632/oncotarget.18040 |
0.37 |
|
| 2016 |
Leu WJ, Swain SP, Chan SH, Hsu JL, Liu SP, Chan ML, Yu CC, Hsu LC, Chou YL, Chang WL, Hou DR, Guh JH. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways. Oncotarget. PMID 27769069 DOI: 10.18632/oncotarget.12765 |
0.393 |
|
| 2016 |
Lin YF, Chen YY, Hsiao YY, Shen CY, Hsu JL, Yeh CM, Mitsuda N, Ohme-Takagi M, Liu ZJ, Tsai WC. Genome-wide identification and characterization of TCP genes involved in ovule development of Phalaenopsis equestris. Journal of Experimental Botany. PMID 27543606 DOI: 10.1093/jxb/erw273 |
0.366 |
|
| 2016 |
Ko HW, Lee HH, Huo L, Xia W, Yang CC, Hsu JL, Li LY, Lai CC, Chan LC, Cheng CC, Labaff AM, Liao HW, Lim SO, Li CW, Wei Y, et al. GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. Oncotarget. PMID 27494834 DOI: 10.18632/oncotarget.11008 |
0.37 |
|
| 2016 |
Fromm PD, Papadimitrious MS, Hsu JL, Van Kooten Losio N, Verma ND, Lo TH, Silveira PA, Bryant CE, Turtle CJ, Prue RL, Vukovic P, Munster DJ, Nagasaki T, Barnard RT, Mahler SM, et al. CMRF-56(+) blood dendritic cells loaded with mRNA induce effective antigen-specific cytotoxic T-lymphocyte responses. Oncoimmunology. 5: e1168555. PMID 27471645 DOI: 10.1080/2162402X.2016.1168555 |
0.316 |
|
| 2016 |
Chen YH, Chung CC, Liu YC, Yeh SP, Hsu JL, Hung MC, Su HL, Li LY. EZH2 and HDAC9c regulate age-dependent mesenchymal stem cell differentiation into osteoblasts and adipocytes. Stem Cells (Dayton, Ohio). PMID 27250566 DOI: 10.1002/Stem.2400 |
0.302 |
|
| 2016 |
Chen YI, Wei PC, Hsu JL, Su FY, Lee WH. NPGPx (GPx7): a novel oxidative stress sensor/transmitter with multiple roles in redox homeostasis. American Journal of Translational Research. 8: 1626-40. PMID 27186289 |
0.307 |
|
| 2016 |
Chou CK, Tsou PH, Hsu JL, Lee HH, Wang YN, Kameoka J, Hung MC. Analysis of Individual Signaling Complexes by mMAPS, a Flow-Proteometric System. Current Protocols in Molecular Biology / Edited by Frederick M. Ausubel ... [Et Al.]. 114: 20.11.1-20.11.22. PMID 27038387 DOI: 10.1002/0471142727.Mb2011S114 |
0.311 |
|
| 2016 |
Du Y, Yamaguchi H, Wei Y, Hsu JL, Wang HL, Hsu YH, Lin WC, Yu WH, Leonard PG, Lee GR, Chen MK, Nakai K, Hsu MC, Chen CT, Sun Y, et al. Blocking c-Met-mediated PARP1 phosphorylation enhances anti-tumor effects of PARP inhibitors. Nature Medicine. PMID 26779812 DOI: 10.1038/Nm.4032 |
0.37 |
|
| 2016 |
Lim SO, Li CW, Xia W, Lee HH, Chang SS, Shen J, Hsu JL, Raftery D, Djukovic D, Gu H, Chang WC, Wang HL, Chen ML, Huo L, Chen CH, et al. EGFR signaling enhances aerobic glycolysis in triple negative breast cancer cells to promote tumor growth and immune escape. Cancer Research. PMID 26759242 DOI: 10.1158/0008-5472.Can-15-2478 |
0.37 |
|
| 2016 |
Li CW, Xia W, Lim SO, Hsu JL, Huo L, Wu Y, Li LY, Lai CC, Chang SS, Hsu YH, Sun HL, Kim J, Yamaguchi H, Lee DF, Wang H, ... Hsu JM, et al. AKT1 inhibits epithelial-to-mesenchymal transition in breast cancer through phosphorylation-dependent Twist1 degradation. Cancer Research. PMID 26759241 DOI: 10.1158/0008-5472.CAN-15-1941 |
0.358 |
|
| 2014 |
Lin CY, Chen HJ, Huang CC, Lai LC, Lu TP, Tseng GC, Kuo TT, Kuok QY, Hsu JL, Sung SY, Hung MC, Sher YP. ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway. Cancer Research. 74: 5229-43. PMID 25060522 DOI: 10.1158/0008-5472.CAN-13-2995 |
0.339 |
|
| 2014 |
Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL, Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, Chang YC, Wang MY, Li CW, Shen J, Chen MK, et al. Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer. Cancer Research. 74: 4822-35. PMID 24970481 DOI: 10.1158/0008-5472.Can-14-0584 |
0.351 |
|
| 2014 |
Xie X, Kong Y, Tang H, Yang L, Hsu JL, Hung MC. Targeted BikDD expression kills androgen-dependent and castration-resistant prostate cancer cells. Molecular Cancer Therapeutics. 13: 1813-25. PMID 24785255 DOI: 10.1158/1535-7163.MCT-13-1004 |
0.336 |
|
| 2014 |
Chou CK, Lee HH, Tsou PH, Chen CT, Hsu JM, Yamaguchi H, Wang YN, Lee HJ, Hsu JL, Lee JF, Kameoka J, Hung MC. mMAPS: a flow-proteometric technique to analyze protein-protein interactions in individual signaling complexes. Science Signaling. 7: rs1. PMID 24595109 DOI: 10.1126/Scisignal.2004620 |
0.323 |
|
| 2013 |
Yu YL, Chou RH, Shyu WC, Hsieh SC, Wu CS, Chiang SY, Chang WJ, Chen JN, Tseng YJ, Lin YH, Lee W, Yeh SP, Hsu JL, Yang CC, Hung SC, et al. Smurf2-mediated degradation of EZH2 enhances neuron differentiation and improves functional recovery after ischaemic stroke. Embo Molecular Medicine. 5: 531-47. PMID 23526793 DOI: 10.1002/emmm.201201783 |
0.323 |
|
| 2013 |
Yamaguchi H, Hsu JL, Chen CT, Wang YN, Hsu MC, Chang SS, Du Y, Ko HW, Herbst R, Hung MC. Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 845-54. PMID 23344263 DOI: 10.1158/1078-0432.CCR-12-2621 |
0.327 |
|
| 2012 |
Xie X, Li L, Xiao X, Guo J, Kong Y, Wu M, Liu W, Gao G, Hsu JL, Wei W, Hung MC, Xie X. Targeted expression of BikDD eliminates breast cancer with virtually no toxicity in noninvasive imaging models. Molecular Cancer Therapeutics. 11: 1915-24. PMID 22752427 DOI: 10.1158/1535-7163.Mct-12-0191 |
0.34 |
|
| 2012 |
Yamaguchi H, Hsu JL, Hung MC. Regulation of ubiquitination-mediated protein degradation by survival kinases in cancer. Frontiers in Oncology. 2: 15. PMID 22649777 DOI: 10.3389/fonc.2012.00015 |
0.384 |
|
| 2012 |
Wang Y, Ding Q, Yen CJ, Xia W, Izzo JG, Lang JY, Li CW, Hsu JL, Miller SA, Wang X, Lee DF, Hsu JM, Huo L, Labaff AM, Liu D, et al. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell. 21: 374-87. PMID 22439934 DOI: 10.1016/j.ccr.2011.12.028 |
0.34 |
|
| 2012 |
Li CW, Xia W, Huo L, Lim SO, Wu Y, Hsu JL, Chao CH, Yamaguchi H, Yang NK, Ding Q, Wang Y, Lai YJ, LaBaff AM, Wu TJ, Lin BR, et al. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1 Cancer Research. 72: 1290-1300. PMID 22253230 DOI: 10.1158/0008-5472.CAN-11-3123 |
0.368 |
|
| 2011 |
Ding Q, Chang CJ, Xie X, Xia W, Yang JY, Wang SC, Wang Y, Xia J, Chen L, Cai C, Li H, Yen CJ, Kuo HP, Lee DF, Lang J, ... Hsu JL, et al. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. The Journal of Clinical Investigation. 121: 4526-36. PMID 21985787 DOI: 10.1172/Jci45008 |
0.337 |
|
| 1999 |
Kuo S, Chesrown SE, Mellott JK, Rogers RJ, Hsu JL, Nick HS. In vivo architecture of the manganese superoxide dismutase promoter. The Journal of Biological Chemistry. 274: 3345-54. PMID 9920876 DOI: 10.1074/Jbc.274.6.3345 |
0.659 |
|
| 1996 |
Hsu JL, Hsieh Y, Tu C, O'Connor D, Nick HS, Silverman DN. Catalytic properties of human manganese superoxide dismutase. The Journal of Biological Chemistry. 271: 17687-91. PMID 8663465 DOI: 10.1074/Jbc.271.30.17687 |
0.539 |
|
| 1992 |
Hurt J, Hsu JL, Dougall WC, Visner GA, Burr IM, Nick HS. Multiple mRNA species generated by alternate polyadenylation from the rat manganese superoxide dismutase gene. Nucleic Acids Research. 20: 2985-90. PMID 1620593 DOI: 10.1093/Nar/20.12.2985 |
0.651 |
|
| 1992 |
Hsu JL, Visner GA, Burr IA, Nick HS. Rat copper/zinc superoxide dismutase gene: isolation, characterization, and species comparison. Biochemical and Biophysical Research Communications. 186: 936-43. PMID 1379810 DOI: 10.1016/0006-291X(92)90836-A |
0.571 |
|
| Show low-probability matches. |